May 19th, 2018
•The protocol presented here describes a platform for identifying small molecules for the treatment of liver disease. A step-by-step description is presented detailing how to differentiate iPSCs into cells with hepatocyte characteristics in 96-well plates, and to use the cells to screen for small molecules with potential therapeutic activity.
Related Videos
Generation of Integration-free Human Induced Pluripotent Stem Cells Using Hair-derived Keratinocytes
Generation of Integration-free Induced Pluripotent Stem Cells from Human Peripheral Blood Mononuclear Cells Using Episomal Vectors
Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
Defined and Scalable Generation of Hepatocyte-like Cells from Human Pluripotent Stem Cells
Integration Free Derivation of Human Induced Pluripotent Stem Cells Using Laminin 521 Matrix
Rapid, Directed Differentiation of Retinal Pigment Epithelial Cells from Human Embryonic or Induced Pluripotent Stem Cells
A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Semi-automated Production of Hepatocyte Like Cells from Pluripotent Stem Cells
Microfluidic Assay for the Assessment of Leukocyte Adhesion to Human Induced Pluripotent Stem Cell-derived Endothelial Cells (hiPSC-ECs)
Generation of 3D Skin Organoid from Cord Blood-derived Induced Pluripotent Stem Cells
Copyright © 2024 MyJoVE Corporation. 판권 소유